Literature DB >> 12519077

Identification by site-directed mutagenesis of amino acids contributing to ligand-binding specificity or signal transduction properties of the human FP prostanoid receptor.

Frank Neuschäfer-Rube1, Eva Engemaier, Sina Koch, Ulrike Böer, Gerhard P Püschel.   

Abstract

Prostanoid receptors belong to the class of heptahelical plasma membrane receptors. For the five prostanoids, eight receptor subtypes have been identified. They display an overall sequence similarity of roughly 30%. Based on sequence comparison, single amino acids in different subtypes of different species have previously been identified by site-directed mutagenesis or in hybrid receptors that appear to be essential for ligand binding or G-protein coupling. Based on this information, a series of mutants of the human FP receptor was generated and characterized in ligand-binding and second-messenger-formation studies. It was found that mutation of His-81 to Ala in transmembrane domain 2 and of Arg-291 to Leu in transmembrane domain 7, which are putative interaction partners for the prostanoid's carboxyl group, abolished ligand binding. Mutants in which Ser-263 in transmembrane domain 6 or Asp-300 in transmembrane domain 7 had been replaced by Ala or Gln, respectively, no longer discriminated between prostaglandins PGF(2alpha) and PGD(2). Thus distortion of the topology of transmembrane domains 6 and 7 appears to interfere with the cyclopentane ring selectivity of the receptor. PGF(2alpha)-induced inositol formation was strongly reduced in the mutant Asp-300Gln, inferring a role for this residue in agonist-induced G-protein activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519077      PMCID: PMC1223288          DOI: 10.1042/BJ20021429

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

Review 1.  Prostanoid receptors: subtypes and signaling.

Authors:  R M Breyer; C K Bagdassarian; S A Myers; M D Breyer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

2.  Amino acid residues conferring ligand binding properties of prostaglandin I and prostaglandin D receptors. Identification by site-directed mutagenesis.

Authors:  T Kobayashi; F Ushikubi; S Narumiya
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

3.  Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter.

Authors:  V L Schuster; S Itoh; S W Andrews; R M Burk; J Chen; K M Kedzie; D W Gil; D F Woodward
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

4.  Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.

Authors:  Y Sugimoto; T Namba; A Honda; Y Hayashi; M Negishi; A Ichikawa; S Narumiya
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.

Authors:  C D Funk; L Furci; N Moran; G A Fitzgerald
Journal:  Mol Pharmacol       Date:  1993-11       Impact factor: 4.436

Review 7.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

Authors:  R A Coleman; W L Smith; S Narumiya
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

8.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

9.  A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs.

Authors:  K M Kedzie; J E Donello; H A Krauss; J W Regan; D W Gil
Journal:  Mol Pharmacol       Date:  1998-09       Impact factor: 4.436

10.  Cloning and expression of a cDNA for the human prostanoid FP receptor.

Authors:  M Abramovitz; Y Boie; T Nguyen; T H Rushmore; M A Bayne; K M Metters; D M Slipetz; R Grygorczyk
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

View more
  5 in total

1.  Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist.

Authors:  Youyong Li; Fangqiang Zhu; Nagarajan Vaidehi; William A Goddard; Felix Sheinerman; Stephan Reiling; Isabelle Morize; Lan Mu; Keith Harris; Ali Ardati; Abdelazize Laoui
Journal:  J Am Chem Soc       Date:  2007-08-11       Impact factor: 15.419

Review 2.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

3.  Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.

Authors:  Andrea Pathe-Neuschäfer-Rube; Frank Neuschäfer-Rube; Gerhard P Püschel
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 4.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

5.  Prediction of the Human EP1 Receptor Binding Site by Homology Modeling and Molecular Dynamics Simulation.

Authors:  Behnoush Zare; Armin Madadkar-Sobhani; Siavoush Dastmalchi; Masoud Mahmoudian
Journal:  Sci Pharm       Date:  2011-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.